Dr. Scott Tomlins, assistant professor of pathology and urology at the University of Michigan Medical School, is the winner of the inaugural Martin and Rose Wachtel Cancer Research Award, presented by the American Association for the Advancement of Science and Science Translational Medicine.

The award, which will be given annually, was funded by an endowment established through a bequest from Martin L. Wachtel. It honors an early career investigator who has performed outstanding work in the field of cancer research.

Tomlins research focuses on genetic mutations that occur in prostate cancer. As part of the Michigan Center for Translational Pathology, he has helped to develop clinical tests to detect a specific gene fusion that occurs in about half of all prostate cancers. This has advanced to a clinical trial testing the potential of targeting treatment to men with that gene fusion.

As part of his award, Tomlins will receive $25,000 and will present a lecture based on his research. An essay about his work is published in Science Translational Medicine.

The award, which will be given annually, was funded by an endowment established through a bequest from Martin L. Wachtel. It honors an early career investigator who has performed outstanding work in the field of cancer research.

Tomlins research focuses on genetic mutations that occur in prostate cancer. As part of the Michigan Center for Translational Pathology, he has helped to develop clinical tests to detect a specific gene fusion that occurs in about half of all prostate cancers. This has advanced to a clinical trial testing the potential of targeting treatment to men with that gene fusion.

As part of his award, Tomlins will receive $25,000 and will present a lecture based on his research. An essay about his work is published in Science Translational Medicine.

Read this article:
ANN ARBOR: U-M professor wins cancer research award

Comments are closed.